Escalating interdictions of oil tankers linked to Venezuelan President Nicolás Maduro occur as part of a sweeping naval ...

Partnership combines Protalix's rare disease and biologics expertise with Secarna's AI–powered OligoCreator® platform to ...

According to the settlement agreement, the proposed biosimilar to Eylea® (aflibercept) can be marketed in the U.S., if ...

BioMarin to Gain Galafold® (migalastat) for Fabry Disease and Pombiliti® (cipaglucosidase alfa-atga) + Opfolda® (miglustat) for Pompe Disease, Adding Two Marketed, High-Growth Products with ...

Discusses Year-End Late-Stage Pipeline Review With Focus on Clinical and Regulatory Developments December 16, 2025 11:15 AM ...

The case examined GST applicability on large-scale plantation and post-plantation maintenance work by a non-profit entity.

Verastem Oncology , a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced strategic leadership changes to accelerate its ...

The deadline to file a claim for money from the $177 million AT&T class action settlement is coming up. AT&T agreed to the settlement to resolve a lawsuit that accused it of failing to protect ...

Light chain amyloidosis is not cancer, but cancer drugs are this rare disease’s standard of care. The patient need for new treatment options has sparked R&D efforts at biotech and big pharmaceutical ...

BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) and Amicus Therapeutics (Nasdaq: FOLD) announced today that BioMarin has entered into a definitive agreement to acquire Amicus for $14.50 per share in an ...

The Australian wife of US rapper Kanye West unveiled the long-teased project, BIO POP (THE ORIGIN), in the South Korean capital on Thursday, shocking fans with an exhibition filled with 'human ...